HLB Co., Ltd. HLB Co., Ltd.

HLB Co., Ltd.

028300

Clasificación en acciones #4150
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Precio por acción
$29.28
Capitalización bursátil
$3.89B
Cambio (1 día)
-1.40%
Cambio (1 año)
-8.45%
País
KR
Comercio HLB Co., Ltd. (028300)

Categoría

Healthcare
Ganancias de HLB Co., Ltd. (028300)
Ganancias en Jun 2026 TTM: $-160.32M
Secondo gli ultimi rapporti finanziari di HLB Co., Ltd., gli utili attuali della società sono $-160.32M. Nel 2023, la società ha registrato un utile di $-164.38M, una disminución en comparación con agli utili del 2022, che erano di $-62.61M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de HLB Co., Ltd. desde 2012 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-160.32M 115.74%
2024 $-74.31M -54.79%
2023 $-164.38M 162.55%
2022 $-62.61M -27.09%
2021 $-85.87M 12.36%
2020 $-76.43M 43.17%
2019 $-53.38M -540.23%
2018 $12.13M -138.75%
2017 $-31.29M 69.49%
2016 $-18.46M -310.93%
2015 $8.75M -632.68%
2014 $-1.64M -80.80%
2013 $-8.56M 40.17%
2012 $-6.11M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -3,390.24%
US
$-3.09B 1,825.53%
US
$-4.02B 2,405.12%
AU
$1.95B -1,316.72%
NL
- -
CH